APA
Hoster E., Geisler C. H., Doorduijn J., van der Holt B., Walewski J., Bloehdorn J., Ribrag V., Salles G., Hallek M., Pott C., Szymczyk M., Kolstad A., Laurell A., Räty R., Jerkeman M., Van't Veer M., Kluin-Nelemans J. C., Klapper W., Unterhalt M., Dreyling M. & Hermine O. (20180309). Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials. : Leukemia.
Chicago
Hoster E, Geisler C H, Doorduijn J, van der Holt B, Walewski J, Bloehdorn J, Ribrag V, Salles G, Hallek M, Pott C, Szymczyk M, Kolstad A, Laurell A, Räty R, Jerkeman M, Van't Veer M, Kluin-Nelemans J C, Klapper W, Unterhalt M, Dreyling M and Hermine O. 20180309. Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials. : Leukemia.
Harvard
Hoster E., Geisler C. H., Doorduijn J., van der Holt B., Walewski J., Bloehdorn J., Ribrag V., Salles G., Hallek M., Pott C., Szymczyk M., Kolstad A., Laurell A., Räty R., Jerkeman M., Van't Veer M., Kluin-Nelemans J. C., Klapper W., Unterhalt M., Dreyling M. and Hermine O. (20180309). Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials. : Leukemia.
MLA
Hoster E, Geisler C H, Doorduijn J, van der Holt B, Walewski J, Bloehdorn J, Ribrag V, Salles G, Hallek M, Pott C, Szymczyk M, Kolstad A, Laurell A, Räty R, Jerkeman M, Van't Veer M, Kluin-Nelemans J C, Klapper W, Unterhalt M, Dreyling M and Hermine O. Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials. : Leukemia. 20180309.